WASHINGTON (AP) — An exhausted Senate narrowly approved a $1.9 trillion COVID-19 relief bill Saturday as President Joe Biden and his Democratic allies notched a victory they called crucial for hoisting the country out of the pandemic and economic doldrums.
After laboring all night on a mountain of amendments — nearly all from Republicans and rejected — bleary-eyed senators approved the sprawling package on a 50-49 party-line vote. That sets up final congressional approval by the House next week so lawmakers can whisk it to Biden for his signature.
The huge measure — its total spending is nearly one-tenth the size of the entire U.S. economy — is Biden’s biggest early priority. It stands as his formula for addressing the deadly virus and a limping economy, twin crises that have afflicted the country for a year.
“This nation has suffered too much for much too long,” Biden told reporters at the White House after the vote. “And everything in this package is designed to relieve the suffering and to meet the most urgent needs of the nation, and put us in a better position to prevail.”
Saturday's vote was also a crucial political moment for Biden and Democrats, who need nothing short of party unanimity in a 50-50 Senate they run with Vice President Kamala Harris' tiebreaking vote. They have a slim 10-vote House edge.
Not a single Republican backed the bill in the Senate or when it initially passed the House, underscoring the barbed partisan environment that's so far characterizing the early days of Biden's presidency.
A small but pivotal band of moderate Democrats leveraged changes in the legislation that incensed progressives, not making it any easier for Speaker Nancy Pelosi, D-Calif., to guide the measure through the House. But rejection of their first, signature bill was not an option for Democrats, who face two years of trying to run Congress with virtually no room for error.
In a significant sign, the chair the Congressional Progressive Caucus, representing around 100 House liberals, called the Senate's weakening of some provisions “bad policy and bad politics” but called them “relatively minor concessions.” Rep. Pramila Jayapal, D-Wash., said the bill retained its “core bold, progressive elements.”
“They feel like we do, we have to get this done,” Senate Majority Leader Chuck Schumer, D-N.Y., said of the House. He said he'd spoken to Pelosi about the Senate's changes and added, “It's not going to be everything everyone wants. No bill is.”
In a written statement, Pelosi invited Republicans "to join us in recognition of the devastating reality of this vicious virus and economic crisis and of the need for decisive action.”
The bill provides direct payments of up to $1,400 for most Americans and extended emergency unemployment benefits. There are vast piles of spending for COVID-19 vaccines and testing, states and cities, schools and ailing industries, along with tax breaks to help lower-earning people, families with children and consumers buying health insurance.
Republicans call the measure a wasteful spending spree for Democrats’ liberal allies that ignores recent indications that the pandemic and economy could be turning the corner.
“The Senate has never spent $2 trillion in a more haphazard way," said Senate Minority Leader Mitch McConnell, R-Ky. Of Democrats, he said, “Their top priority wasn't pandemic relief. It was their Washington wish list.”
The Senate commenced a dreaded “vote-a-thon” — a continuous series of votes on amendments — shortly before midnight Friday, and by its end around noon had dispensed with about three dozen. The Senate had been in session since 9 a.m. EST Friday.
Overnight, the chamber was like an experiment in the best techniques for staying awake. Several lawmakers appeared to rest their eyes or doze at their desks, often burying their faces in their hands. At one point, Sen. Brian Schatz, D-Hawaii, at 48 one of the younger senators, trotted into the chamber and did a prolonged stretch.
Sen. Dan Sullivan, R-Alaska, missed the votes to attend his father-in-law’s funeral.
The measure follows five earlier ones totaling about $4 trillion that Congress has enacted since last spring and comes amid signs of a potential turnaround.
Vaccine supplies are growing, deaths and caseloads have eased but remain frighteningly high, and hiring was surprisingly strong last month, though the economy remains 10 million jobs smaller than its pre-pandemic levels.
The Senate package was delayed repeatedly as Democrats made eleventh-hour changes aimed at balancing demands by their competing moderate and progressive factions.
Work on the bill ground to a halt Friday after an agreement among Democrats on extending emergency jobless benefits seemed to collapse. Nearly 12 hours later, top Democrats and West Virginia Sen. Joe Manchin, perhaps the chamber's most conservative Democrat, said they had a deal, and the Senate approved it on a party-line 50-49 vote.
Under their compromise, $300 weekly emergency unemployment checks — on top of regular state benefits — would be renewed, with a final payment made Sept. 6. There would also be tax breaks on some of those payments, helping people the pandemic abruptly tossed out of jobs and risked tax penalties on the benefits.
The House's relief bill, largely similar to the Senate's, provided $400 weekly benefits through August. The current $300 per week payments expire March 14, and Democrats want the bill on Biden's desk by then to avert a lapse.
Manchin and Republicans have asserted that higher jobless benefits discourage people from returning to work, a rationale most Democrats and many economists reject.
The agreement on jobless benefits wasn't the only move that showed moderates' sway.
The Senate voted Friday to eject a House-approved boost in the federal minimum wage to $15 an hour by 2025, a major defeat for progressives. Eight Democrats opposed the increase, suggesting that Sen. Bernie Sanders, I-Vt., and other liberals pledging to continue the effort in coming months will face a difficult fight.
Party leaders also agreed to restrict eligibility for the $1,400 stimulus checks that will go to most Americans. That amount would be gradually reduced until, under the Senate bill, it reaches zero for people earning $80,000 and couples making $160,000. Those amounts were higher in the House version.
Many of the rejected GOP amendments were either attempts to force Democrats to cast politically awkward votes or for Republicans to demonstrate their zeal for issues that appeal to their voters.
These included defeated efforts to bar funds from going to schools that don't reopen their doors or let transgender students born male participate in female sports. One amendment would have blocked aid to so-called sanctuary cities, where local authorities don't help federal officials round up immigrants in the U.S. illegally.
Associated Press writers Lisa Mascaro and Kevin Freking contributed to this report.
Pandemic year 2: Vaccines, variants, and other developments
Pandemic year 2: Vaccines, variants, and other developments

A year after the COVID-19 pandemic first arrived on American soil, the U.S. still has a long way to go before the coronavirus is under control. But this second year of life with SARS-CoV-2 has started off with a bang, with a new White House administration promising major changes to the nation’s pandemic response and millions of vaccine doses being administered daily.
While the Moderna and Pfizer vaccines were the big news of 2020—and are now being injected into the arms of over a million Americans each day—2021 has brought new vaccine trial results from Novavax, Johnson & Johnson, and Russia’s Sputnik V. Some results have been more promising than others, stirring experts to debate the balance between vaccine effectiveness and the challenges of availability and distribution. Meanwhile, researchers are scrambling to learn how each of these vaccines will perform when met with the new variants of SARS-CoV-2 that are taking hold across the globe.
The Biden administration has been announcing executive orders and new initiatives left and right, putting more scientists in charge of pandemic response and pushing to get vaccines to as many Americans as possible. The CDC has continued to issue new guidelines as they’ve developed more safety measures to prevent transmission of the virus, like suggesting doubling up on masks and guidelines on how to keep school kids safe during in-person classes.
With so much changing every day, it can be hard to keep up with all the news. That’s why Stacker has constructed a timeline of how the COVID-19 pandemic has played out so far in 2021, using White House briefings and news reports. Here’s what President Biden and his administration have accomplished since he took office in January, and what the virus—and its novel variants—have been up to since then.
You may also like: How the most common jobs in America are impacted by COVID-19
Jan. 20-21: Biden takes office, issues executive orders

President Joe Biden wasted no time after his Jan. 20 inauguration ceremony. He signed 15 executive orders during his first day in office, several of which related to the COVID-19 pandemic. He mandated masks and social distancing in federal buildings, set up a specific department to coordinate the federal response to the pandemic, rejoined the World Health Organization, and extended the moratoriums on foreclosures, evictions, and student loan payments.
Jan. 25, Jan. 28: New coronavirus variants from Brazil and South Africa reported in the US

Two new, more contagious variants of SARS-CoV-2 were detected in the United States in late January. The P.1 variant made its way to Minnesota by way of a resident who had traveled to Brazil, while the two South Carolina patients carrying the B.1.351 variant from South Africa had no history of travel to countries where the variant has been confirmed.
Jan. 26: Biden administration purchases 200 million vaccine doses

To vaccinate all 300 million Americans with the necessary two doses, health care providers will need 600 million units of the vaccine. That’s why the Biden administration announced that by summer it will have purchased the additional 200 million shots needed to meet that mark.
Jan. 27: First press briefing with new White House COVID-19 team

Jeffrey Zients, the White House COVID-19 response coordinator, led the Biden administration's first press briefing on the pandemic. Immediate goals include increasing the number of both vaccination sites and health care providers who can administer the vaccines. In general, the message was one of urgency—plus relief to have scientists back at the helm of the nation’s pandemic response.
Jan. 28: Novavax releases vaccine trial results

Preliminary clinical trial results from the United Kingdom showed that the Novavax vaccine was 94% effective against the virus. Results from a study in South Africa were less promising, with only 49% effectiveness.
You may also like: 20 ways COVID-19 is impacting children around the world
Jan. 28: Biden expands Affordable Care Act coverage

The White House opened a “special enrollment period” for the Affordable Care Act after determining that millions of Americans eligible for ACA health coverage remain uninsured. President Biden also took steps to roll back Trump-era policies like work requirements for Medicaid and limitations for Americans with pre-existing medical conditions.
Jan. 29: Johnson & Johnson releases vaccine trial results

Like the Novavax results the day before, clinical trial results for the Johnson & Johnson vaccine disappointed some experts with just a 66% effectiveness against moderate to severe COVID-19. These results varied by location, with effectiveness slightly higher in the U.S. (72%) and lower in Latin America (66%) and South Africa (57%). However, with only a single shot, the vaccine prevented serious disease progression—hospitalization or death—which means it could still find a place in the world’s overall pandemic response.
Feb. 1: More Americans vaccinated than have tested positive

By the start of February, 32.8 million vaccine doses had been administered in the U.S.—more doses than the number of people who have tested positive since the virus first reached the U.S. in January 2020. Just over 6 million people had already received both doses by this date, and the U.S. continues to administer over a million shots per day.
Feb. 2: Results for Russia's Sputnik V vaccine

The more vaccine options, the merrier. Russia announced results from its Sputnik V clinical trials: 91.6% effective against symptomatic COVID-19, and 100% effective against severe disease progression. No severe or moderate cases were reported in the vaccinated group of 14,964 people.
Feb. 6: Over 2 million vaccinations in one day

For the first time, the U.S. administered over 2 million vaccinations in a single day, bringing the national tally to over 40 million doses administered and more than 8 million people fully vaccinated.
You may also like: 50 indicators for understanding America's economy right now
Feb. 9: WHO task force examines virus origins

The WHO task force investigating the origins of SARS-CoV-2 in China held a press briefing on Feb. 9, announcing that they’d found no evidence that the virus jumped straight from bats to humans, or that it could have escaped from the virus lab in Wuhan. An intermediate carrier for the disease is currently the most likely hypothesis, though much more research is needed to confirm.
Feb. 10: COVID-19 Health Equity Task Force members announced

The White House announced the members of a new COVID-19 task force focused on reducing health inequities exacerbated by the ongoing pandemic. The team will work to analyze issues such as disparities in COVID-19 cases, hospital stays, and deaths among racial and geographic lines.
Feb. 10: CDC recommends doubling up on masks

Two masks are better than one: The Centers for Disease Control and Prevention officially recommended doubling up on masks to improve protection against COVID-19. The CDC especially recommends layering a cloth mask over a surgical mask, but in general, the idea is to improve the seal around the edges of often ill-fitting masks.
Feb. 12: CDC releases new guidance on school reopenings

Long-awaited guidance on school reopenings arrived on Feb. 12, when the CDC announced new, science-based strategies for determining how and when to reopen K-12 schools. In general, the guidelines say that depending on current community transmission rates, schools may be safe to reopen as long as they follow proper masking, social distancing, handwashing, cleaning, and contact tracing protocol.
Feb. 14: Over 1,000 reported cases of B.1.1.7 variant

The CDC is closely following the progression of the new coronavirus variants in the U.S. The B.1.351 variant, first identified in South Carolina, has now shown up 21 times in 10 states, while the P.1 variant first found in Minnesota has been reported five times in four states. But there's another strain, B.1.1.7, which is ringing alarm bells: It’s up to 1,523 reported cases in 42 states as of Feb. 18.
You may also like: States with the biggest nursing home outbreaks of COVID-19
Feb. 21: 500,000 Americans have died from COVID-19

According to an NBC News tally, the U.S. reached a new milestone on Feb. 21: 500,000 deaths from COVID-19. Other trackers, such as Johns Hopkins and the CDC, haven’t reached this milestone yet due to differences in accounting, but they will likely cross that threshold within a few days. California leads the rankings with over 49,000 deaths.
You may also like: States receiving the most PPE from the federal government
Feb. 27: Johnson & Johnson vaccine authorized by FDA

The U.S. added a third COVID-19 vaccine to its arsenal when the Food & Drug Administration (FDA) gave Emergency Use Authorization to Johnson & Johnson. 3.9 million doses of this vaccine—the first shown to prevent severe COVID-19 disease with a single dose—were shipped out the next day, to be administered during the week of March 1. While that initial 3.9 million doses represents the entirety of Johnson & Johnson's current supply, the pharmaceutical company has promised to ramp up its production. It is expected to deliver 16 million doses to the U.S. by the end of March and 100 million by summer 2021.
March 2: States begin lifting mask restrictions, opening 100%

Multiple states in the first week of March peeled back mask mandates and other restrictions related to COVID-19, with Mississippi and Texas announcing the lifting all restrictions and West Virginia following close behind 6 barring some sustained restrictions for standing room congregation. Alabama, Arizona, and Connecticut similarly loosened rules. Throughout the pandemic, some states including Alaska and Georgia resisted ever implementing statewide mask mandates.